Memory Pharmaceuticals To Present At The Rodman And Renshaw Techvest 7th Annual Healthcare Conference

MONTVALE, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that Jim Sulat, President and Chief Executive Officer, will provide a Company update at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference on November 9th at 9:45 a.m. EST, at the New York Palace Hotel in New York City.

Interested parties may access a live audio webcast of the presentation by visiting the Investor Relations section of Memory Pharmaceuticals’ website at http://www.memorypharma.com. An archived version of the webcast will be available at the same location through November 15, 2005.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression, vascular dementia, mild cognitive impairment, Parkinson’s disease and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com.

Memory Pharmaceuticals Corp.

CONTACT: Jzaneen Lalani, Vice President, Legal Affairs of MemoryPharmaceuticals Corp., +1-201-802-7140; or Laura Perry of Stern InvestorRelations, Inc., +1-212-362-1200

MORE ON THIS TOPIC